Zantac / Ranitidine (NDMA Cancer) Attorney in Denver, Colorado

Zantac Litigation in Denver

Denver-area Zantac claimants are served by one of the nation's top NCI-designated cancer centers at the University of Colorado — providing excellent documentation of cancer diagnosis, staging, and treatment. Colorado applies Daubert under CRE 702. Given the federal MDL's Daubert dismissal, Denver-area claimants should consult national plaintiffs' counsel about Delaware Superior Court filing, where Judge Medinilla's docket has allowed Zantac causation experts to proceed. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Denver Zantac Claimants

Denver-area Zantac claimants should obtain pharmacy records from King Soopers (Kroger), Safeway, Walgreens, and CVS pharmacies. UColorado Cancer Center and UCHealth records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. Colorado's 2-year SOL applies from the date of discovery of the cancer diagnosis and its potential Zantac link.